The eHealth specialist InterComponentWare AG (ICW) was chosen as technology partner, which is providing the web-based personal health record LifeSensor for the three-year research study. BARMER, Germany's largest health insurance provider, starts evaluating the effects of the personal health record on the health behavior and the situation for the provision of health care to its insured as part of a Germany-wide research study. 
Cardiovascular diseases are the world's number one killer. Globally, over 17 million people die from such diseases each year, and it's estimated that the number of cardiac patients will increase by 34% over the next four years. For cardiologists, this translates into a growing pressure to treat more patients in less time. Technology is already helping cardiologists to meet this challenge at many stages in the care cycle. But too often new technology means new levels of complexity. 
Anoto Group, the pioneer in Digital Pen & Paper (DPP) technology, has launched the Anoto Forms Solution, a ready-made hardware and software package that will enable the healthcare market to roll out DPP applications more quickly and easily. 
SHL Telemedicine Ltd. (SWX: SHLTN), a leading provider and developer of advanced personal telemedicine solutions, announced that its German subsidiary PHTS Telemedizin will provide telemedicine services in the Coburg region (north of Bavaria, Germany). Private health insurer HUK-Coburg-Krankenversicherung is joining insurer Deutsche BKK in a project with the Klinikum Coburg for the region of Coburg. PHTS Telemedizin, the wholly owned German subsidiary of SHL Telemedicine Ltd. (SWX:SHLTN), has appointed Prof. Dr. med. Christoph A. Nienaber to its Medical Advisory Board. The renowned cardiologist strengthens PHTS Telemedizin with his cardiological competence and profound know-how in the implementation of telemedicine. 
An innovative neurological findings and documentation system named "NEMESYS" has been developed in the Department of Clinical Neurophysiology at Göttingen University School of Medicine. As regards content NEMESYS was developed in the Department of Clinical Neurophysiology at the University Hospital Göttingen (UKG) by Professor (Prof. Dr.) W. Paulus, Director of the Department of Clinical Neurophysiology, and private lecturer (Priv. Doz. Dr. med.) F. Tergau, St. Bernward Hospital in Hildesheim, formerly Department of Clinical Neurophysiology of the UKG. Technically NEMESYS was developed by Dipl. Phys. J. Lessing (Faculty of Physics).